Improved glycaemic control decreases inner mitochondrial membrane leak in type 2 diabetes

Diabetes, Obesity and Metabolism

Volumn 11, Issue 4, 2009, Pages 355-360

  Rabøl, Rabøl ^a,b,c   Hojberg P M V ^b   Almdal, T ^b   Boushel, R ^a   Haugaard, S B ^b   Madsbad, S ^b   Dela, F ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Etomoxir; Glucagon; Glucose; Insulin; Islets; Palmitate

Indexed keywords

ADENOSINE DIPHOSPHATE; ANTIDIABETIC AGENT; GLUTAMIC ACID; HEMOGLOBIN A1C; INSULIN; INSULIN ASPART; ISOPHANE INSULIN; MALIC ACID; OLIGOMYCIN; PYRUVIC ACID; SUCCINIC ACID; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DELTOID MUSCLE; FEMALE; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; INSULIN TREATMENT; MALE; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; MUSCLE BIOPSY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RESPIRATION CONTROL; RESPIROMETRY; VASTUS LATERALIS MUSCLE; WEIGHT GAIN; BLOOD; CELL RESPIRATION; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; MUSCLE MITOCHONDRION; PHYSIOLOGY; SKELETAL MUSCLE;

ADULT; AGED; BLOOD GLUCOSE; CELL RESPIRATION; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; MITOCHONDRIA, MUSCLE; MITOCHONDRIAL MEMBRANES; MUSCLE, SKELETAL;

EID: 61549133253     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2008.00977.x     Document Type: Article

References (36)

1. Saraste M. Oxidative phosphorylation at the fin de siecle. Science 1999; 283: 1488-1493.
2. Brand MD, Brindle KM, Buckingham JA, Harper JA, Rolfe DF, Stuart JA. The significance and mechanism of mitochondrial proton conductance. Int J Obes Relat Metab Disord 1999; 23(Suppl. 6): S4-11.
3. Kadenbach B. Intrinsic and extrinsic uncoupling of oxidative phosphorylation. Biochim Biophys Acta 2003; 1604: 77-94.
4. Harper ME, Dent R, Monemdjou S, et al. Decreased mitochondrial proton leak and reduced expression of uncoupling protein 3 in skeletal muscle of obese diet-resistant women. Diabetes 2002; 51: 2459-2466.
5. Gnaiger E. Bioenergetics at low oxygen: Dependence of respiration and phosphorylation on oxygen and adenosine diphosphate supply. Respir Physiol 2001; 128: 277-297.
6. Purnell JQ, Weyer C. Weight effect of current and experimental drugs for diabetes mellitus: From promotion to alleviation of obesity. Treat Endocrinol 2003; 2: 33-47.
7. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 837-853.
8. Colditz GA, Willett WC, Stampfer MJ, et al. Weight as a risk factor for clinical diabetes in women. Am J Epidemiol 1990; 132: 501-513.
9. Yki-Jarvinen H, Ryysy L, Kauppila M, et al. Effect of obesity on the response to insulin therapy in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1997; 82: 4037-4043.
10. Weight gain associated with intensive therapy in the diabetes control and complications trial. The DCCT Research Group. Diabetes Care 1988; 11: 567-573.
11. Makimattila S, Nikkila K, Yki-Jarvinen H. Causes of weight gain during insulin therapy with and without metformin in patients with type II diabetes mellitus. Diabetologia 1999; 42: 406-412.
12. Carlson MG, Campbell PJ. Intensive insulin therapy and weight gain in IDDM. Diabetes 1993; 42: 1700-1707.
13. Heller S. Weight gain during insulin therapy in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 2004; 65(Suppl. 1): S23-S27.
14. Wolfe RR. Effects of insulin on muscle tissue. Curr Opin Clin Nutr Metab Care 2000; 3: 67-71.
15. Kersten S. Mechanisms of nutritional and hormonal regulation of lipogenesis. EMBO Rep 2001; 2: 282-286.
16. Bogardus C, Taskinen MR, Zawadzki J, Lillioja S, Mott D, Howard BV. Increased resting metabolic rates in obese subjects with non-insulin-dependent diabetes mellitus and the effect of sulfonylurea therapy. Diabetes 1986; 35: 1-5.
17. Jacob AN, Salinas K, ms-Huet B, Raskin P. Weight gain in type 2 diabetes mellitus. Diabetes Obes Metab 2007; 9: 386-393.
18. Magnusson I, Rothman DL, Katz LD, Shulman RG, Shulman GI. Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. J Clin Invest 1992; 90: 1323-1327.
19. Boushel R, Gnaiger E, Schjerling P, Skovbro M, Kraunsoe R, Dela F. Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia 2007; 50: 790-796.
20. Kunz WS, Kuznetsov AV, Schulze W, et al. Functional characterization of mitochondrial oxidative phosphorylation in saponin-skinned human muscle fibers. Biochim Biophys Acta 1993; 1144: 46-53.
21. Kuznetsov AV, Wiedemann FR, Winkler K, Kunz WS. Use of saponin-permeabilized muscle fibers for the diagnosis of mitochondrial diseases. Biofactors 1998; 7: 221-223.
22. Saks VA, Veksler VI, Kuznetsov AV, et al. Permeabilized cell and skinned fiber techniques in studies of mitochondrial function in vivo. Mol Cell Biochem 1998; 184: 81-100.
23. Brownlee M. The pathobiology of diabetic complications: A unifying mechanism. Diabetes 2005; 54: 1615-1625.
24. Wing RR, Marcus MD, Epstein LH, Salata R. Type II diabetic subjects lose less weight than their overweight nondiabetic spouses. Diabetes Care 1987; 10: 563-566.
25. Guare JC, Wing RR, Grant A. Comparison of obese NIDDM and nondiabetic women: Short- and long-term weight loss. Obes Res 1995; 3: 329-335.
26. Soboll S. Thyroid hormone action on mitochondrial energy transfer. Biochim Biophys Acta 1993; 1144: 1-16.
27. Goglia F, Silvestri E, Lanni A. Thyroid hormones and mitochondria. Biosci Rep 2002; 22: 17-32.
28. Silva JE. Thermogenic mechanisms and their hormonal regulation. Physiol Rev 2006; 86: 435-464.
29. Goglia F, Moreno M, Lanni A. Action of thyroid hormones at the cellular level: The mitochondrial target. FEBS Lett 1999; 452: 115-120.
30. Cadenas S, Buckingham JA, Samec S, et al. UCP2 and UCP3 rise in starved rat skeletal muscle but mitochondrial proton conductance is unchanged. FEBS Lett 1999; 462: 257-260.
31. Hesselink MK, Greenhaff PL, Constantin-Teodosiu D, et al. Increased uncoupling protein 3 content does not affect mitochondrial function in human skeletal muscle in vivo. J Clin Invest 2003; 111: 479-486.
32. Schrauwen P, Hesselink MK. The role of uncoupling protein 3 in fatty acid metabolism: Protection against lipotoxicity? Proc Nutr Soc 2004; 63: 287-292.
33. Harper JA, Dickinson K, Brand MD. Mitochondrial uncoupling as a target for drug development for the treatment of obesity. Obes Rev 2001; 2: 255-265.
34. Boirie Y. Insulin regulation of mitochondrial proteins and oxidative phosphorylation in human muscle. Trends Endocrinol Metab 2003; 14: 393-394.
35. Boirie Y, Short KR, Ahlman B, Charlton M, Nair KS. Tissue-specific regulation of mitochondrial and cytoplasmic protein synthesis rates by insulin. Diabetes 2001; 50: 2652-2658.
36. Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002; 51: 2944-2950.